Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Mouth Neoplasms × advexin × Clear all

Phase

Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Tongue Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplasm Metastasis 1 Mouth Neoplasms 1 Head and Neck Neoplasms 1

Interventions

Cisplatin 4 Radiotherapy 2 Paclitaxel 2 tozuleristide 1 pembrolizumab 1 niraparib 1 dostarlimab 1 dacomitinib 1 advexin 1 Taxes 1 Sirolimus 1 Pemetrexed 1 Gemcitabine 1 Fluorodeoxyglucose F18 1 FPP(RGD)2 1 Chemoprevention 1 Amifostine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00064103 2013-01-23

Gene Therapy in Preventing Cancer in Patients With Premalignant Carcinoma of the Oral Cavity or Pharynx

National Cancer Institute (NCI)

Phase 1/2 Completed

Mouth Neoplasms, Oropharyngeal Neoplasms, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡